Nanologica - Model NLAB - Silica
From Drug Development
Nanologica’s patented technology platform, NLAB Silica™, enables the use of mesoporous silica for tailor-made drug delivery systems for enhanced bioavailability and controlled release. The technology has been applied to many projects in both research and commercial collaborations, validating Nanologica’s concepts of how silica-based drug delivery systems can add value to the pharmaceutical product.
Products Details
NLAB Silica™ particles solves problems in pharmaceutical formulations by improving solubility, enhancing bioavailability and protecting APIs from degradation.
Picture: Reformulation of the HIV drug Atazanavir (ATV) using NLAB Silica™ for improved bioavailability in vivo
If you would like to know more about Nanologica’s drug delivery technology, please contact Adam Feiler, CTO
Customer reviews
No reviews were found for Nanologica - Model NLAB - Silica. Be the first to review!